This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Hang on a second…

This CME Activity has expired and is no longer available for credit.

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Shifting Paradigms, Emerging Treatments in Moderate to Severe Atopic Dermatitis

Shifting Paradigms, Emerging Treatments in Moderate to Severe Atopic Dermatitis

Format

Expert Perspective

Time to Complete

2 hours

Released

February 10, 2017

Expires

September 10, 2017
Add to Queue


Maximum Credits

2.00 / AMA PRA Category 1 Credit(s)TM
2.00 / CE for Pharmacists (0.20 CEUs)
2.00 / CE for Nurses

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

This activity is supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Program Description

David Bernstein, MD, and Amy Paller, MD, combine their expertise and discuss emerging concepts, treatment advancements, and critical issues associated with the management of patients with atopic dermatitis. The discussion focuses on real-world patient management and includes case studies to facilitate integration of new knowledge into clinical practice.

Intended Audience

This activity was developed for dermatologists, allergists, pediatricians, primary care physicians, nurse practitioners, nurses, pharmacists, and other healthcare professionals who have an interest in atopic dermatitis (AD).

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Examine the epidemiology and pathogenesis of AD and the relevance to the management of patients with AD
  • Integrate a proactive approach to long-term disease management in AD, with a focus on prevention of flares, assessment of disease activity, and patient education
  • Discuss the mechanisms, efficacy, and safety data for emerging biologic therapies and which patients are likely to benefit

Conflict Of Interest Disclosure Policy

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Faculty

David I. Bernstein, MD
Professor of Medicine and Environmental Health
Division of Immunology, Allergy, and Rheumatology
University of Cincinnati College of Medicine
Cincinnati, OH

David I. Bernstein, MD discloses the following:
Research Support: Allergy Therapeutics, Amgen, AstraZeneca, Boehringer Ingelheim, Circassia, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Teva
Consultant: AstraZeneca, Merck, Teva
Speaker's Bureau: Merck

Amy S. Paller, MD
Walter J. Hamlin Professor and Chair of Dermatology
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL

Amy S. Paller, MD discloses the following:
Research Support: AbbVie, Leo Foundation
Employee: Amgen, Astellas, Celgene
Consultant: Amgen, Galderma, GSK-Stiefel, Lilly, Novartis, Pfizer/Anacor, Sanofi/Regeneron, Vitae

Disclosure of Unlabeled Use
The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

Planners' and Managers' Disclosures

Annenberg Center for Health Sciences
John Bayliss, VP
, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Additional content planners
The following have no significant relationship to disclose:
Eugene Cullen, MD (peer reviewer)
Gregory Scott, PharmD, RPh (medical writer)
Sally Schermer, BSN, MBA (nurse planner)

Credit

2.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.00 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

2.00

Type

CE for Pharmacists

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

This program has been assigned ACPE Universal Program #0797-0000-17-015-H04-P. This program is designated for up to 2.00 contact hours (0.20 CEU) of continuing pharmacy education credit.

Credit

2.00

Type

CE for Nurses

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

A maximum of 2.00 contact hours may be earned for successful completion of this activity.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Instructions

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications in your practice, and completing the assessment component.

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue